Revenue: As of FY2026 Q1, the actual value is USD 75.41 M, beating the estimate of USD 74.4 M.EPS: As of FY2026 Q1, the actual value is USD 0.06, missing the estimate of USD 0.09.EBIT: As of FY2026 Q1, the actual value is USD 4.601 M.<h4>Revenue</h4><ul><li>Viemed Healthcare, Inc. reported total revenue of $75,414 thousand for Q1 2026, marking a 28% year-over-year increase from $59,129 thousand in Q1 2025.</li><li>Ventilators, non-invasive &amp; invasive rental revenue was $35,360 thousand in Q1 2026, up from $32,159 thousand in Q1 2025, representing 46.9% of total revenue in Q1 2026 compared to 54.4% in Q1 2025.</li><li>Other home medical equipment rentals revenue increased to $16,198 thousand in Q1 2026 from $12,962 thousand in Q1 2025, accounting for 21.5% of total revenue in Q1 2026, which was unchanged from 21.9% in Q1 2025.</li><li>Equipment and supply sales revenue significantly rose to $17,488 thousand in Q1 2026 from $7,519 thousand in Q1 2025, representing 23.2% of total revenue in Q1 2026, up from 12.7% in Q1 2025.</li><li>Service revenues were $6,368 thousand in Q1 2026, a decrease from $6,489 thousand in Q1 2025, and represented 8.4% of total revenue in Q1 2026, down from 11.0% in Q1 2025.</li></ul><h4>Operational Metrics</h4><ul><li>Gross profit for Q1 2026 was $42,827 thousand, reflecting a 57% gross profit margin, compared to $33,279 thousand and a 56% gross profit margin in Q1 2025.</li><li>Net income attributable to Viemed Healthcare, Inc. was $2,582 thousand in Q1 2026, slightly lower than $2,625 thousand in Q1 2025.</li><li>Adjusted EBITDA grew 12% year-over-year to $14,311 thousand in Q1 2026, up from $12,765 thousand in Q1 2025.</li><li>Total assets as of March 31, 2026, amounted to $197,361 thousand.</li><li>Working capital as of March 31, 2026, was $9,105 thousand.</li><li>Long term debt as of March 31, 2026, stood at $8,334 thousand.</li></ul><h4>Cash Flow</h4><ul><li>Operating cash flow generated was $8,071 thousand for Q1 2026.</li><li>Free cash flow for Q1 2026 was $2,586 thousand.</li><li>Net capital expenditures (Net CAPEX) for Q1 2026 were - $5,485 thousand.</li><li>Trailing twelve months (TTM) free cash flow was $36,344 thousand as of March 31, 2026.</li></ul><h4>Unique Metrics</h4><ul><li>Sleep platform patients increased by 57% year-over-year, with new patient starts rising by 42%.</li><li>Ventilator patient growth remained stable at 2% year-over-year, reaching 12,089 patients in Q1 2026.</li><li>PAP Therapy Patients increased to 35,938 in Q1 2026 from 22,899 in Q1 2025, while Sleep Resupply Patients grew to 33,661 in Q1 2026 from 22,941 in Q1 2025.</li><li>The company repurchased 150,000 shares for $1.4 million and reduced debt by $3.2 million through term loan repayments.</li><li>As of March 31, 2026, Viemed Healthcare, Inc. had $46 million in unfunded commitments available under existing credit facilities.</li></ul><h4>Outlook / Guidance</h4><ul><li>For the full year 2026, Viemed Healthcare, Inc. narrowed and raised its net revenue guidance to $312 million to $320 million, and reaffirmed its Adjusted EBITDA guidance at $65 million to $69 million.</li><li>Net capital expenditures are now projected to be 9% to 10.5% of net revenue, an update from the previous range of 10% to 11.5%.</li></ul>

Viemed Healthcare | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 75.41 M